Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...
The FDA approved pembrolizumab (Keytruda) with chemotherapy as first-line treatment ... said major generic drugmakers told ...
A study found that reducing the dose of pembrolizumab in patients with advanced stage non–small cell lung cancer did not ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...
After announcing a phase 3 launch based on positive midstage results, iTeos and GSK are finally sharing the highlights from ...
The 2024 Alcazar will continue to compete with the MG Hector Plus, and based on the revealed images, we can expect the Alcazar to offer these 7 additional features over the MG Hector Plus ...
The trial evaluated monotherapy ivonescimab against monotherapy Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in patients with locally advanced or metastatic non-small cell lung cancer ...
Summit Therapeutics’s drug ivonescimab reduced the risk of lung cancer progression or death by nearly half, compared to MSD’s blockbuster drug Keytruda (pembrolizumab) in Phase III data showcased on 8 ...
Merck’s Keytruda Combo for Urothelial Carcinoma Gets EU Approval: The European Commission granted approval to Merck’s Keytruda in combination with Astellas/Pfizer’s antibody-drug conjugate ...
Coinciding with a cost-of-living crisis, MG’s cheapies are filling Aussie driveways, trumping the likes of Nissan and Subaru to be our seventh best-selling brand. 2024 MG HS. Photo: Supplied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback